Treatment of Acne Vulgaris with Topical Unani Compound Formulation

Assessing the Therapeutic effects of Topical Unani Compound Formulation for Treating Acne Vulgaris (Buthur-e-labaniyya): Randomized, Standard-Controlled Clinical Trial. - Nill

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080103

Enrollment

Registered

2025-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Powder of Kalonji (Nigella sativa)and Anjeer (Ficus carica Linn.) mixed with Sirka (vinegar). : Form Zimad (Cream) Mode of application Topical Dosage Quantity sufficient once daily Cont

Eligibility

Inclusion criteria

Inclusion criteria: participants with comedones, papules,pustules,nodules,itching and erythema participants willing for written voluntary consent.

Exclusion criteria

Exclusion criteria: 1 Patient with other associated disorders like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc. 2 Patient on corticosteroid therapy, Anticonvulsant therapy, or taking oral contraceptive pills for last 1 month. 3 Pregnant and lactating women. 4 Patients suffering with other previously diagnosed severe systemic illness.

Design outcomes

Primary

Measure	Time frame
Global Acne Grading System (GAGS) Cook s Acne Grading Scale (using photographic standards) Timepoint: baseline 30th 60th and 90th	—

Secondary

Measure	Time frame
Quality of Life by Cardiff Acne Disability Index (CADI)Timepoint: Baseline and After Trial	—

Countries

India

Contacts

Public ContactDr Saba Mamdapur

Luqman Unani Medical College Hospital and Research Centre VijayaPura Karnataka 586101

drmqkhan@yahoo.com9849438319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026